SMid Cap Biotech Analyst Joseph holds a conference call with President & CEO Mainolfi on June 4 at 1 pm hosted by JPMorgan. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KYMR:
- Kymera presents clinical data from ongoing Phase 1 trial of MDM2 Degrader KT-253
- Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting
- Kymera Therapeutics to Participate in Upcoming June Investor Conferences
- Kymera Therapeutics to present new clinical data for KT-253 at ASCO
- Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the ATS Annual Meeting